-+ 0.00%
-+ 0.00%
-+ 0.00%

JASPER THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN FIRST COHORT OF PHASE 2 RENAL BASKET STUDY EVALUATING VENSOBAFUSP ALFA (KP104) IN IGA NEPHROPATHY

Reuters·10/15/2026 12:00:04

Please log in to view news